Nonsteroidal anti-inflammatory drugs and cancer prevention.
about
Microbial induction of immunity, inflammation, and cancerThe Role of PPARgamma Receptors and Leukotriene B(4) Receptors in Mediating the Effects of LY293111 in Pancreatic CancerMyeloid-derived suppressor cells: linking inflammation and cancerInflammation and cancerEffects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysisNon steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and realitySalicylate-induced growth arrest is associated with inhibition of p70s6k and down-regulation of c-myc, cyclin D1, cyclin A, and proliferating cell nuclear antigenEpidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged > or =70Effect of diet, life style, and other environmental/chemopreventive factors on colorectal cancer development, and assessment of the risksThe public health potential of aspirinRisk of cancer in a large cohort of nonaspirin NSAID users: a population-based studyIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesLung injury, inflammation and Akt signaling following inhalation of particulate hexavalent chromiumLoss of TFF1 is associated with activation of NF-κB-mediated inflammation and gastric neoplasia in mice and humansSuppressive oligodeoxynucleotides reduce lung cancer susceptibility in mice with silicosis.trans-Fatty acid consumption and its association with distal colorectal cancer in the North Carolina Colon Cancer Study IIAssociations between trans fatty acid consumption and colon cancer among Whites and African Americans in the North Carolina colon cancer study IGlutathione Peroxidase 7 Suppresses Bile Salt-Induced Expression of Pro-Inflammatory Cytokines in Barrett's Carcinogenesis.Loss of glutathione peroxidase 7 promotes TNF-α-induced NF-κB activation in Barrett's carcinogenesis.Neutrophilic airways inflammation in lung cancer: the role of exhaled LTB-4 and IL-8.A novel naproxen derivative capable of displaying anti-cancer and anti-migratory properties against human breast cancer cellsCelecoxib: a new option in the treatment of arthropathies and familial adenomatous polyposis.Multistage carcinogenesis and the incidence of colorectal cancer.The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role.HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress.Quantitative assessment of the effect of cytochrome P450 2C9 gene polymorphism and colorectal cancerEffect of suppressive oligodeoxynucleotides on the development of inflammation-induced papillomasThe role of NSAIDs in the prevention of colon cancer.Prevalence of colorectal adenomatous polyps in patients with chronic obstructive pulmonary disease.Significance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancerSignificance of arachidonic acid in ocular infections and inflammation.Direct toxicity of nonsteroidal antiinflammatory drugs for renal medullary cells.Dietary D-glucarate effects on the biomarkers of inflammation during early post-initiation stages of benzo[a]pyrene-induced lung tumorigenesis in A/J mice.Clinical research in primary stroke prevention: needs, opportunities, and challenges.Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis.Non-steroidal anti-inflammatory drugs in prevention of gastric cancer.Intake of trans fat and all-cause mortality in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) cohortClinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter.Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice.Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo.
P2860
Q21129264-BA3D5A0E-3504-403C-B02B-4A1A8D974BD9Q21342813-8591FDFA-2AE7-491D-8A0D-9C5BE3DE4094Q24641811-D2A3DABE-987B-48E4-A4DB-A6FBAE46DCC3Q24649640-688C0016-EE59-473C-9442-A476997A92C8Q24796323-42BE5F18-1F4A-44A5-A181-828434B7E67AQ28166312-5E9F2CF3-6035-4FB1-9EE8-9058E0E7384EQ28174689-EC46D006-B42F-4F84-8353-B65D4CFCCAF7Q28175859-7FED8F24-D2F2-4BEA-A8CA-EE4D3ECE4671Q28193397-19DAE224-53BF-457F-9403-718DE8022658Q28194137-D03AB2D5-E51F-462F-9ACE-ED3C532CC093Q28196301-0FC1CFDF-CFC0-42E0-920C-6E2C23F30464Q28388335-FCF2A4A4-A744-4A44-B91B-010913B16B43Q28397511-6DA9FEF8-3C48-4CF3-903B-46195D56FE33Q30432425-9B50DCB9-15F2-42A1-9372-BD1F531EE7BBQ33585368-7DFF8A28-0DF1-422D-9F63-572D7145FDD1Q33604194-AED32855-E918-48C4-BE18-5FDB216CB80EQ33784687-029D40A2-FFBD-40A7-80D7-F7A71037B178Q33794355-4B45102C-1726-42AF-ABA3-CE181A11D73EQ33827698-D9071334-20FE-4221-BF34-960F1BB53F41Q33925759-7FF33610-AE49-4478-8768-245DE3F9CFE5Q34048391-D3EBE722-55AD-48B8-9910-CF683FD86318Q34240778-087A7CA1-FCD3-40A2-9F56-F683303B3175Q34381339-99B81C62-2B33-43B6-81CF-C400BA2239BAQ34547396-DA480255-2B02-41BD-8572-1B2827A61908Q34566683-440AB782-A9AE-400D-B9B3-1D4A5F8DD7E1Q34663842-C998E895-BA98-459B-9F54-8AD311981656Q34939860-686EB140-FC43-4902-BA83-AB6D50ABFEA0Q35008304-BA3CFC11-7DB7-43FA-A23A-B2071EBD4643Q35636693-657D1A6F-29AF-45AA-8AF9-B7A58DD75A18Q35651537-91A23684-44D2-4D42-9E12-B77A2C857C5DQ35737348-1ED0DBA2-DF0C-437E-BABE-3D65AD35BB87Q35873816-BAAE27BE-597F-4A4F-9B46-C1218FB09B8EQ36142630-2A52DC1C-340B-4523-971C-B93B1E6EDB3DQ36163351-169C00D7-6B15-4083-9AA0-84577D310C33Q36370513-3F2F18CB-7299-4ED8-B9AC-F0BB47494345Q36485784-360AA50F-F2D5-4B81-92C8-552FCC715734Q36772104-590323EA-2F32-431C-82B7-C1D3B910E892Q36891938-1FEC641E-15A8-4ECA-A98F-2B19E11EFDCCQ36982546-A063A373-5F93-42C3-A6C5-FA653FDF8462Q37000921-2B9050E9-B634-41AA-9E04-FC2B402824A9
P2860
Nonsteroidal anti-inflammatory drugs and cancer prevention.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Nonsteroidal anti-inflammatory drugs and cancer prevention.
@ast
Nonsteroidal anti-inflammatory drugs and cancer prevention.
@en
type
label
Nonsteroidal anti-inflammatory drugs and cancer prevention.
@ast
Nonsteroidal anti-inflammatory drugs and cancer prevention.
@en
prefLabel
Nonsteroidal anti-inflammatory drugs and cancer prevention.
@ast
Nonsteroidal anti-inflammatory drugs and cancer prevention.
@en
P1476
Nonsteroidal anti-inflammatory drugs and cancer prevention.
@en
P2093
P304
P356
10.1146/ANNUREV.MED.51.1.511
P577
2000-01-01T00:00:00Z